$SJM — AVOID 📊 | 6 MONTHS THESIS

$SJM — AVOID 📊 | 6 MONTHS THESIS 🎯 FQ4 FY2027 (ends Apr) | reported Jun 09 | Rev $2.3B | EPS $3.63 vs $2.64 🟢 | Margin -23.4% 💡 Consensus expected $2.64, a figure that materially underestimated the stickiness of SJM's core brands and the one-and-done nature of the $507.5M impairment. The gap was closed by the reported beat; current expectations may now be overly optimistic about the pace of balance-sheet repair and the durability of cost cuts, leaving little room for... 🏢 Business Quality: 3 — iconic brands (Smucker’s, Folgers) but burdened by a bloated cost structure, negative operating margins on a GAAP basis, and heavy leverage that leaves minimal cash flow for debt reduction or reinvestment./10 📊 Valuation: cheap on an adjusted trailing P/E of 8.0x (vs. peers 15–20x), but fair on a risk-adjusted basis given the GAAP net margin of -31% and net debt/EBITDA... 🔮 Catalyst: next earnings report (FQ1 FY2028, around September 2026) ⚖️ Avoid: the 37% EPS beat is stale news, the und

🎯 FQ4 FY2027 (ends Apr) | reported Jun 09 | Rev $2.3B | EPS $3.63 vs $2.64 🟢 | Margin -23.4%